Marcus Gibson

Marcus Gibson

Company: Omega Therapeutics

Job title: Associate Director, Hit-To-Lead Optimization Platform

Seminars:

Roundtable Discussion: Implementing Computational Strategies for Designing Non-Coding RNA Sequences to Achieve Gene Editing & Expression Regulation 2:00 pm

Investigating how AI/ML can be used to optimize non-coding RNA sequences for tasks such as gene editing or regulating gene expression How to use AI/ML to identify cleavage probability of microRNA and siRNAs Highlighting the potential of computational tools to predict non-coding RNA interactions with the RNA targetRead more

day: Day Two

Panel Discussion: Identifying Strategies for Data Sharing or Smaller Model Development to Improve Cost Feasibility of AI/ML Models for RNA & Lipid Design 3:45 pm

Discussing the potential of collaboration and data sharing between companies to accelerate data access for optimizing computational algorithms Evaluating the true impact of data quantity on computational model accuracy and prediction capability How to improve the cost efficiency of developing computational models for RNA design to make them more accessibleRead more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.